Skip to main content

Correspondence

Buy Article:

$34.78 + tax (Refund Policy)

Clarithromycin for non-mycobacterial diseases? Pattisapu R. J. Gangadharam, Microbiology and Pathology, Director of Mycobacteriology Research, University of Illinois, Chicago, Illinois, USA

Sputum microscopy at 2 and 3 months. D. Wilkinson, CERSA-HLABISA, Hlabisa, Kwa-Zulu Natal, South Africa

In reply. Michael Levy, Clovelly, Australia; and Zhao Feng-zeng, Tuberculosis Control Project Office, Ministry of Health, Beijing, China

The origins of DOT. D. A. Mitchison, Department of Medical Microbiology, St George's Hospital Medical School, London, UK

In reply. John A. Sbarbaro, University of Colorado Health Sciences Center, Denver, Colorado, USA

Document Type: Letter Paper

Publication date: 01 October 1998

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content